Navigation Links
Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
Date:12/11/2007

become infected with HBV this year.

About Hepatitis C

Hepatitis C is a blood-borne infectious disease of the liver and is a leading cause of chronic liver disease and liver transplants. The WHO estimates that nearly 180 million people worldwide, or approximately 3% of the world's population, are infected with hepatitis C virus (HCV). The CDC has reported that almost four million people in the United States have been infected with HCV, of whom 2.7 million are chronically infected.

Contact

Alan Roemer, Vice President

Investor Relations & Corporate Communications

alan.roemer@pharmasset.com

Office: (609) 613-4125

Pegasys(R) and Copegus(R) are registered trademarks of Roche.

Forward-Looking Statements

Pharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without limitation the risk that adverse events could cause the cessation of the Phase 3 registration studies and/or our development of clevudine, the risk that adverse events could cause the cessation of the Phase 1 combination study and/or our development of R7128, the risk that our collaboration with Roche will not continue or will not be successful and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of these risks and uncertainties, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2007 filed with the Securities and Exchange Commission entitled "Risk Factors" and discussions of potential risks and uncertainties in our subsequent filings with the Securities and Exchange Commi
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... MONTREAL , 21. November 2014 ... hat heute bekannt gegeben, dass ... – EMA) die Kennzeichnung als Orphan-Medizinprodukt ... Produktkandidat des Unternehmens zur Behandlung von ... eine seltene, stark beeinträchtigende genetische Krankheit, ...
(Date:11/21/2014)... , Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... , Chief Executive Officer, will be presenting at the 26 ... York Palace Hotel in New York . ... at 2:00 PM ET. In addition, Mr. Krakauer and ... for separate one-on-one meetings during the day. ...
(Date:11/21/2014)... -- Depomed, Inc. (NASDAQ: DEPO ) today announced that ... Annual Healthcare Conference in New York City . ... for 8:00 am EST (5:00 am PST) on Tuesday December 2, ... accessed via the Investor Relations page of the Depomed website at ... for 30 days on the company,s website. About ...
Breaking Medicine Technology:Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2
... IBM ) scientists have developed a flexible, non-contact ... researchers and pathologists to investigate critical tissue samples ... Flickr Photos: http://www.flickr.com/photos/ibm_research_zurich/sets/72157628678347543 ... pathology to detect disease markers in a patient,s ...
... CITY, Calif., Jan. 12, 2012  Cardica, Inc. (Nasdaq: ... in its European clinical trial of the MicroCutter XPRESS™ ... the XPRESS 30 did not perform satisfactorily in thicker ... requires modifications to the product. There have been no ...
Cached Medicine Technology:MADE IN IBM LABS: New Silicon Probe Assists in Disease Diagnostics and Drug Discovery 2MADE IN IBM LABS: New Silicon Probe Assists in Disease Diagnostics and Drug Discovery 3MADE IN IBM LABS: New Silicon Probe Assists in Disease Diagnostics and Drug Discovery 4Cardica Provides Update on MicroCutter™ Program 2Cardica Provides Update on MicroCutter™ Program 3Cardica Provides Update on MicroCutter™ Program 4
(Date:11/21/2014)... Florida (PRWEB) November 21, 2014 TruDenta, ... chronic headaches and other jaw-related symptoms, has ... seeking relief from chronic head pain, neck pain, TMJ ... , “This year we have seen a 52% increase ... Our network of over 300 doctors and their teams ...
(Date:11/21/2014)... CDT PLUS! 2015 represents the ... everything needed to process dental insurance claims. View ... CDT 2015 codes are mandatory for reporting dental procedures ... 31, 2014. Dental professionals must use HIPAA mandated CDT ... There are significant changes in the CDT coding system ...
(Date:11/21/2014)... MO (PRWEB) November 21, 2014 ... Melancholy Lift, an industry leader in the ... people have significant feelings of sadness and depression ... from traditional pharmaceutical choices. Often, prescription drugs can ... depression. Prescription drugs are expensive and require regular ...
(Date:11/21/2014)... 21, 2014 According to a National ... June 11th, 2014, the inflating system found in certain ... airbag inflates. The force of inflation may cause the ... metal shards may pierce the airbag’s fabric and potentially ... , According to a Bloomberg Business Week article ...
(Date:11/21/2014)... London, UK (PRWEB) November 21, 2014 ... only ISO verified healthcare professional panel, today announced two important ... appointment of Roni DasGupta as President of Market Research, Americas ... Market Research, Europe. , Ms. DasGupta joined M3 ... President and most recently Head of Sales. Roni has ...
Breaking Medicine News(10 mins):Health News:National Rise In Patients Seeking Headache Relief 2Health News:PMIC Announces CDT PLUS! 2015, the Ultimate Coding Reference for Dentists and Oral Surgeons 2Health News:Depression Relief Product Receives Top 5-Star Rating from TopConsumerReviews.com 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 3Health News:M3 Global Research Announces Leadership Team Promotions in US and EU 2
... of unregulated tobacco products, the World Health Organisation (WHO) ... prevent more than five million deaths each year attributed ... anti-tobacco programmes, especially aimed at adolescent girls, among whom ... use, it finds, also continued to expand most rapidly ...
... public services watchdog, the hospitals in Scotland are failing to ... condition known as ‘Deep vein thrombosis’ (DVT), wherein a blood ... ,An enquiry that was conducted in the cases of ... the failure to diagnose the condition had resulted in the ...
... a doctor, today examined patients at the All India Institute ... end their strike or face termination of service. // ... terminate them from service,' he said when asked about the ... return to work., ,The minister, wearing the doctors' white ...
... The Supreme Court today has issued a notice to ... which a policy decision to implement 27 per cent ... quota issue continuing, the Supreme Court today decided to ... cent reservation to socially and economically backward classes in ...
... the students to end their agitation on the reservation issue. ... so contempt// action can be initiated against the students. ... left "patients at the mercy of God". ,"We ... If they are over-reaching our orders, they are in for ...
... President A P J Abdul Kalam today met representatives ... break the impasse with the students and doctors deciding// ... of agitating medicos, which also included members of AIIMS ... had a 45-minute meeting with Kalam. The medicos presented ...
Cached Medicine News:Health News:Hospitals In Scotland Not Diagnosing DVT Properly 2Health News:Supreme Court Verdict Gives Hope to Striking Medicos 2Health News:Supreme Court Warns Medicos of Contempt Action 2Health News:President Kalam Meets Striking Medicos However Stir to Continue 2
Titanium hemi arthroplasty implant for degenerative and post-traumatic arthritis of first metatarsophalangeal joint....
... Ad-Techs Cueva Cranial Nerve Electrodes ... skull base surgeries. Their patented circumferential ... nerve, and yields high-quality, stable real-time ... with valuable information during the removal ...
... As with all of Ad-Techs products, our Sphenoidal ... quality. They are available in stainless steel or ... or 2.75 inch (70 mm) long, 21 gauge ... electrodes are supplied as kits or sets. You ...
... is a medical device designed to handle ... capability, and archiving demands of the EEG ... framework that helps organize workflow and the ... centralized database and powerful search capability keeps ...
Medicine Products: